Seattle, WA, United States of America

Cosman

This inventor holds 1 USPTO granted patent. Top assignee: Immunex Corporation. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Cosman

Introduction

Cosman is a notable inventor based in Seattle, WA, who has made significant contributions to the field of biochemistry. His work primarily focuses on the purification and characterization of the interleukin-2 receptor, which plays a crucial role in immune response.

Latest Patents

Cosman holds a patent for the "Purification of the IL-2 receptor." This invention details a method for purifying the interleukin-2 receptor derived from both normal and malignant cells. The purification process employs various techniques, including affinity chromatography in conjunction with a monoclonal antibody directed to the receptor. Additionally, reversed-phase high-performance liquid chromatography is utilized to achieve high purity. This meticulous purification has enabled the sequencing of the amino acid residues at the N-terminal of the protein molecule.

Career Highlights

Cosman is associated with Immunex Corporation, where he has contributed to groundbreaking research in immunology. His patent has paved the way for advancements in understanding the interleukin-2 receptor, which is vital for therapeutic applications in treating various diseases.

Collaborations

Throughout his career, Cosman has collaborated with esteemed colleagues such as Douglas Pat Cerretti and Steven K Dower. These collaborations have further enhanced the research and development of innovative solutions in the field.

Conclusion

Cosman's work exemplifies the impact of innovative research in biochemistry and immunology. His contributions, particularly in the purification of the interleukin-2 receptor, have significant implications for future medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…